Prevalence of sleep aid medication use in patients receiving a hematopoietic cell transplant on an inpatient unit

Rachel Cusatis, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USAFollow
Antony Ibrahim, Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
Jennifer M. Knight, Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
Anita D'Souza, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA
Bronwen E. Shaw, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA

Abstract

Background and objectives: There is a lack of research regarding the use of sleep aids after hematopoietic stem cell transplantation (HCT). We describe the prevalence of sleep aid administration in the HCT unit and identify associations with patient or clinical characteristics. Patients and methods: In this retrospective analysis of sequential inpatient HCTs from July 1 to December 31, 2016 we describe whether and when patients were prescribed sleep aid medications. Chi-square tests determined significant differences between patient characteristics, sleep aid prescription, and time of prescription. Results: Of the 225 patients identified, 193 (86%) were prescribed sleep aids. Significantly more women received prescriptions for sleep aids (90.4%) than men (81%; P ¼ .047). One hundred patients (44%) received prescriptions exclusively while in the hospital. Conclusion: Findings show a high prevalence of sleep medication use in patients undergoing inpatient HCT, primarily during hospitalization. Future efforts toward standardized recommendations to optimize peri-transplant sleep would help clinicians and patients.

Recommended Citation

Cusatis, Rachel; Ibrahim, Antony; Knight, Jennifer M.; D'Souza, Anita; and Shaw, Bronwen E. (2022) "Prevalence of sleep aid medication use in patients receiving a hematopoietic cell transplant on an inpatient unit," Hematology/Oncology and Stem Cell Therapy: Vol. 16 : Iss. 4 , Article 11.
Available at: https://doi.org/10.56875/2589-0646.1036